MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15 · Effective Apr 17, 2022
11 active Medicare policies list Z72.53, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
National · Effective Aug 6, 2026
5 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z72.53 |
|---|---|---|
| Diagnosis of Vaginitis | Jan 3, 2024 | Covered |
| Herpes Simplex Virus - Screening and Diagnosis | Aug 22, 2023 | Covered |
| Orthopoxvirus Vaccines | Mar 15, 2024 | Covered |
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
| Policy | Effective | Status of Z72.53 |
|---|---|---|
| Nucleic Acid Pathogen Testing | Aug 15, 2026 |
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
| Covered |